Literature DB >> 20354779

The androgen receptor in breast cancer: learning from the past.

Michaela J Higgins1, Antonio C Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20354779     DOI： 10.1007/s10549-010-0864-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  6 in total

1.  Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Authors:  Ulla Simanainen; Yan Ru Gao; Kirsty A Walters; Geoff Watson; Reena Desai; Mark Jimenez; David J Handelsman
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

2.  Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.

Authors:  Lin Zhao; Fengting Niu; Honghong Shen; Xiaozhen Liu; Lijuan Chen; Yun Niu
Journal:  Virchows Arch       Date:  2016-03-30       Impact factor: 4.064

3.  Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.

Authors:  Pierluigi Gasparini; Matteo Fassan; Luciano Cascione; Gulnur Guler; Serdar Balci; Cigdem Irkkan; Carolyn Paisie; Francesca Lovat; Carl Morrison; Jianying Zhang; Aldo Scarpa; Carlo M Croce; Charles L Shapiro; Kay Huebner
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

Review 4.  Breast Cancer: Targeting of Steroid Hormones in Cancerogenesis and Diagnostics.

Authors:  Marcela Valko-Rokytovská; Peter Očenáš; Aneta Salayová; Zuzana Kostecká
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

5.  A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro and tumor growth in vivo.

Authors:  Lijie Zhao; Xin Han; Jianfeng Lu; Donna McEachern; Shaomeng Wang
Journal:  Neoplasia       Date:  2020-10       Impact factor: 5.715

6.  Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes.

Authors:  Sandra Orrù; Emanuele Pascariello; Giovanni Sotgiu; Daniela Piras; Laura Saderi; Maria Rosaria Muroni; Ciriaco Carru; Caterina Arru; Cristina Mocci; Giampietro Pinna; Raffaele Barbara; Paolo Cossu-Rocca; Maria Rosaria De Miglio
Journal:  Biomedicines       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.